Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-01-26

Clinical Trial Update: GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery [Phase 1, Phase 2]

View source ↗

Summary

A two-phase clinical trial investigating GM-CSF, fosfomycin, and metronidazole for pouchitis in ulcerative colitis patients post-restorative IPAA surgery. Phase…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosfomycin (Fosfomycin)
  • GM-CSF (granulocyte-macrophage colony-stimulating factor)
  • METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: Zealand University Hospital | Conditions: Pouchitis | Phase 1, Phase 2 | Status: UNKNOWN